Stock listing
Dusseldorf:22Z Zealand Pharma A/S Aktie
German listing (Dusseldorf) of Zealand Pharma A/S · home listing Copenhagen:ZEAL
Follow Zealand Pharma A/S into a list and get an email when it puts out news.
Home listing price · OMXCOP:ZEAL
234.10 DKK +2.10 (+0.9%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, OMXCOP:ZEAL
- Day range
- 229.70 – 234.70 DKKOct 30, 2026
- Volume
- 246,053 sharesOct 30, 2026
- Market cap
- 15.53B DKKAt the close on Oct 30, 2026 · price × 66.33M shares outstanding
- 52-week range
- 220.60 – 556.00 DKKLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- 107.6M DKKMedian day 355,213 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Copenhagen:ZEAL · Home | 234.10 DKK | +2.10 (+0.9%) | 246,053 | 231.10 | 234.70 | 229.70 | 232.00 | Close on Oct 30, 2026 |
| OTC:ZLDPF | $33.88 USD | -0.62 (-1.8%) | 117 | $33.88 | $33.88 | $33.88 | $34.50 | Close on Oct 23, 2026 |
| Frankfurt:22Z | €30.64 EUR | +0.66 (+2.2%) | — | €30.64 | €30.64 | €30.64 | €29.98 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · OMXCOP:ZEAL · DKK, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 234.10 | +2.10 | +0.9% | 231.10 | 234.70 | 229.70 | 246,053 | |
| 232.00 | +2.80 | +1.2% | 229.00 | 235.10 | 227.60 | 392,276 | |
| 229.20 | +3.20 | +1.4% | 227.00 | 231.30 | 225.40 | 421,940 | |
| 226.00 | +2.70 | +1.2% | 224.10 | 227.20 | 221.10 | 445,402 | |
| 223.30 | -2.70 | -1.2% | 227.70 | 230.80 | 223.30 | 327,135 | |
| 226.00 | -5.40 | -2.3% | 231.40 | 233.90 | 226.00 | 240,251 | |
| 231.40 | -0.30 | -0.1% | 230.00 | 233.50 | 227.60 | 361,656 | |
| 231.70 | +1.90 | +0.8% | 230.00 | 234.10 | 226.70 | 356,535 | |
| 229.80 | +8.00 | +3.6% | 221.80 | 230.30 | 221.80 | 371,921 | |
| 221.80 | -4.50 | -2.0% | 228.00 | 229.00 | 220.60 | 294,403 | |
| 226.30 | -3.10 | -1.4% | 230.00 | 231.20 | 224.80 | 340,390 | |
| 229.40 | +2.10 | +0.9% | 227.00 | 229.40 | 223.10 | 406,644 | |
| 227.30 | -4.00 | -1.7% | 232.00 | 234.60 | 226.80 | 357,835 | |
| 231.30 | -3.50 | -1.5% | 236.00 | 237.00 | 228.60 | 304,051 | |
| 234.80 | -3.20 | -1.3% | 238.70 | 239.80 | 232.60 | 340,404 | |
| 238.00 | +1.00 | +0.4% | 240.00 | 241.70 | 236.00 | 306,966 | |
| 237.00 | -12.40 | -5.0% | 250.00 | 250.60 | 235.50 | 582,587 | |
| 249.40 | -1.70 | -0.7% | 249.90 | 253.00 | 245.30 | 325,226 | |
| 251.10 | -14.50 | -5.5% | 270.00 | 271.10 | 251.00 | 320,421 | |
| 265.60 | -0.30 | -0.1% | 267.80 | 269.80 | 260.50 | 435,771 | |
| 265.90 | +11.40 | +4.5% | 254.50 | 267.80 | 251.60 | 554,452 | |
| 254.50 | -16.60 | -6.1% | 273.20 | 274.00 | 236.90 | 1,213,844 | |
| 271.10 | +2.60 | +1.0% | 268.50 | 274.20 | 266.40 | 356,775 | |
| 268.50 | +0.50 | +0.2% | 268.70 | 273.80 | 266.30 | 313,514 | |
| 268.00 | -4.70 | -1.7% | 272.90 | 276.90 | 267.10 | 249,310 | |
| 272.70 | -3.20 | -1.2% | 278.10 | 281.00 | 271.00 | 289,249 | |
| 275.90 | +0.40 | +0.1% | 275.20 | 279.10 | 272.70 | 262,029 | |
| 275.50 | -5.70 | -2.0% | 283.00 | 284.40 | 275.50 | 268,786 | |
| 281.20 | +4.80 | +1.7% | 280.20 | 282.80 | 272.30 | 311,052 | |
| 276.40 | -5.60 | -2.0% | 286.40 | 286.40 | 273.00 | 355,213 | |
| 282.00 | -0.90 | -0.3% | 283.20 | 292.20 | 279.80 | 794,181 | |
| 282.90 | +10.00 | +3.7% | 274.00 | 283.50 | 273.70 | 315,843 | |
| 272.90 | -4.30 | -1.6% | 276.30 | 278.00 | 271.00 | 405,037 | |
| 277.20 | -1.50 | -0.5% | 278.90 | 280.30 | 275.10 | 256,935 | |
| 278.70 | +0.50 | +0.2% | 278.20 | 287.90 | 277.50 | 355,971 | |
| 278.20 | -6.00 | -2.1% | 284.20 | 285.50 | 277.90 | 434,046 | |
| 284.20 | -9.00 | -3.1% | 290.50 | 292.30 | 284.20 | 473,258 | |
| 293.20 | -4.10 | -1.4% | 296.00 | 296.70 | 289.10 | 410,328 | |
| 297.30 | -7.40 | -2.4% | 301.00 | 304.40 | 297.30 | 399,047 | |
| 304.70 | -0.70 | -0.2% | 305.10 | 309.40 | 304.20 | 196,787 | |
| 305.40 | -5.10 | -1.6% | 313.00 | 317.20 | 305.40 | 309,045 | |
| 310.50 | +6.80 | +2.2% | 305.00 | 319.70 | 304.00 | 462,627 | |
| 303.70 | +1.70 | +0.6% | 301.00 | 318.20 | 301.00 | 482,663 | |
| 302.00 | +2.00 | +0.7% | 301.00 | 310.00 | 298.70 | 343,392 | |
| 300.00 | -12.90 | -4.1% | 309.50 | 309.50 | 297.00 | 907,920 | |
| 312.90 | -4.10 | -1.3% | 318.90 | 325.00 | 312.90 | 286,237 | |
| 317.00 | +2.10 | +0.7% | 319.30 | 322.30 | 315.40 | 292,652 | |
| 314.90 | -12.00 | -3.7% | 328.00 | 330.90 | 313.50 | 391,438 | |
| 326.90 | +17.50 | +5.7% | 311.40 | 331.90 | 311.40 | 613,276 | |
| 309.40 | -11.80 | -3.7% | 322.20 | 322.30 | 308.80 | 384,144 | |
| 321.20 | +6.60 | +2.1% | 320.20 | 326.30 | 311.50 | 472,821 | |
| 314.60 | -6.80 | -2.1% | 322.60 | 325.50 | 314.60 | 313,033 | |
| 321.40 | +9.80 | +3.1% | 311.00 | 326.00 | 309.10 | 343,046 | |
| 311.60 | -3.00 | -1.0% | 311.00 | 316.80 | 307.20 | 328,182 | |
| 314.60 | -6.60 | -2.1% | 324.10 | 328.30 | 312.00 | 470,905 | |
| 321.20 | -20.00 | -5.9% | 343.00 | 351.00 | 321.20 | 568,824 | |
| 341.20 | +12.00 | +3.6% | 348.20 | 348.90 | 330.00 | 458,430 | |
| 329.20 | -5.90 | -1.8% | 335.00 | 335.10 | 324.50 | 292,287 | |
| 335.10 | +9.10 | +2.8% | 327.40 | 338.00 | 325.00 | 232,484 | |
| 326.00 | -5.00 | -1.5% | 332.50 | 335.60 | 323.10 | 215,153 | |
| 331.00 | +2.70 | +0.8% | 330.00 | 342.20 | 330.00 | 375,507 | |
| 328.30 | +2.40 | +0.7% | 325.80 | 331.40 | 323.90 | 257,901 | |
| 325.90 | +7.70 | +2.4% | 321.70 | 327.30 | 316.40 | 260,166 | |
| 318.20 | +11.60 | +3.8% | 312.00 | 321.40 | 307.80 | 463,382 | |
| 306.60 | +2.60 | +0.9% | 304.20 | 309.90 | 303.60 | 149,865 | |
| 304.00 | -0.90 | -0.3% | 305.00 | 315.20 | 300.50 | 445,543 | |
| 304.90 | -0.20 | -0.1% | 304.40 | 305.00 | 299.90 | 200,340 |
- Ticker
- Dusseldorf:22Z
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Dusseldorf
- Currency
- EUR
What changed lately
Latest news release · Oct 1, 2026
Zealand Pharma A/S announces Boehringer Ingelheim's survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes
Latest deck · Aug 13, 2026
Q2 2026 Earnings Presentation
Earnings · 14 slides
Latest news
Zealand Pharma A/S announces Boehringer Ingelheim's survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes
Oct 1, 2026
Closed 254.50 (-6.1%) on Oct 1, 2026
Zealand Pharma to present additional data from Phase 2 ZUPREME-1 trial for petrelintide at EASD 2026 and announces publication of trial results in The Lancet Diabetes & Endocrinology
Sep 29, 2026
Closed 271.10 (+1.0%) on Sep 30, 2026
Zealand Pharma - Transactions related to share buy-back program (week 39, 2026)
Sep 28, 2026
Closed 268.50 (+0.2%) on Sep 29, 2026
Zealand Pharma - Transactions related to share buy-back program (week 38, 2026)
Sep 21, 2026
Closed 281.20 (+1.7%) on Sep 22, 2026
Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome
Sep 18, 2026
Closed 282.00 (-0.3%) on Sep 18, 2026
Zealand Pharma - Transactions related to share buy-back program (week 37, 2026)
Sep 14, 2026
Closed 277.20 (-0.5%) on Sep 15, 2026
Zealand Pharma to participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Sep 9, 2026
Closed 284.20 (-3.1%) on Sep 10, 2026
Zealand Pharma - Transactions related to share buy-back program (week 36, 2026)
Sep 7, 2026
Closed 297.30 (-2.4%) on Sep 8, 2026
Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
Aug 31, 2026
Closed 302.00 (+0.7%) on Sep 1, 2026
Zealand Pharma – Notification of holding of treasury shares
Aug 24, 2026
Closed 326.90 (+5.7%) on Aug 25, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 14 slides · Aug 13, 2026
Q1 2026 Earnings Presentation
Earnings · 17 slides · May 7, 2026
Barclays 28th Annual Global Healthcare Conference (March 2026)
Conference · 7 slides · Mar 11, 2026
Petrelintide Phase 2 ZUPREME-1 topline data conference call (March 2026)
Conference · 20 slides · Mar 5, 2026
Zealand Pharma A/S on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 65 in the last 12 months · 82 in all · newest Oct 1, 2026 · oldest 2025
- Decks
- 51 decks · latest Aug 13, 2026
Where Zealand Pharma A/S is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Copenhagen:ZEAL · Home listing | Copenhagen | Denmark | DKK |
| LSIN:0NZU | LSIN | United Kingdom | DKK |
| gettex:22Z | gettex | Germany | EUR |
| Stuttgart:22Z | Stuttgart | Germany | EUR |
| OTC:ZLDPF | OTC | United States | USD |
| Tradegate:22Z | Tradegate | Germany | EUR |
| LS Exchange:A0YJW7 | LS Exchange | Germany | EUR |
| OTC:ZLDPY | OTC | United States | USD |
| Aquis:ZEALC | Aquis | United Kingdom | DKK |
| Lang & Schwarz:A0YJW7 | Lang & Schwarz | Germany | EUR |
| Frankfurt:22Z | Frankfurt | Germany | EUR |
| Turquoise:ZEALC | Turquoise | United Kingdom | DKK |
| VIE:ZEAL | Vienna | Austria | EUR |
| BX Swiss:ZEAL | BX Swiss | Switzerland | CHF |
| Dusseldorf:22Z · This page | Dusseldorf | Germany | EUR |
| Munich:22Z | Munich | Germany | EUR |
| Xetra:22Z | Xetra | Germany | EUR |
| Aquis:ZEALC | Aquis | United Kingdom | DKK |
| Frankfurt:22Z1 | Frankfurt | Germany | EUR |
| Hamburg:22Z | Hamburg | Germany | EUR |
| Hanover:22Z | Hanover | Germany | EUR |
Log in to ask 6ix AI your own questions about Zealand Pharma A/S.